Pharma Companies Regulations Treatment 
Drug Target Review
DECEMBER 20, 2024
Smith states, weve definitely come across people in the pharma industry who worry that AI means companies might steal our data or use it in harmful ways. As the industry gains more exposure to AIs real-world applications and the rigorous standards AI companies adhere to, trust will continue to grow.
Vial
FEBRUARY 15, 2024
Factors such as patient access and safety, infrastructure, site experience in clinical research, trial phase requirements, suitability for treatment, and ethical concerns must be carefully considered during site selection3,4. Their ability to adapt to evolving regulations and industry standards reduces the likelihood of costly setbacks.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
MAY 23, 2023
Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.
H1 Blog
DECEMBER 11, 2024
While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. Furthermore, as pharma looks to offset future price controls, the prices of new drugs will likely spike.
H1 Blog
AUGUST 17, 2023
In this blog post, we’ll explore various approaches to key opinion leader identification and HCP engagement and strategy planning and look at a best practices case study where H1 helped a top global pharma reach more than 1,200 new DOLs.
Altus Drug Development
JUNE 28, 2022
Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. The purpose of research and development in the pharmaceutical industry is the incremental innovation of medicinal products and treatments. What is a value-added medicine? To comply with the law.
Advarra
JULY 19, 2022
Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. A: Yes, the EUA is just temporary. is this acceptable to the FDA?
Expert insights. Personalized for you.
128 
Let's personalize your content